Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival

医学 肺癌 间变性淋巴瘤激酶 肿瘤科 内科学 腺癌 放射治疗 癌症 表皮生长因子受体 人口 化疗 阶段(地层学) 靶向治疗 古生物学 恶性胸腔积液 环境卫生 生物
作者
Anna May Suidan,Laila C. Roisman,Anna Belilovski Rozenblum,Maya Ilouze,Elizabeth Dudnik,Alona Zer,Nir Peled
出处
期刊:Journal of Global Oncology [American Society of Clinical Oncology]
卷期号:5 (5): 1-8 被引量:62
标识
DOI:10.1200/jgo.18.00216
摘要

Lung cancer (LC) is the leading cause of cancer mortality worldwide. Despite advances in the treatment strategy, including surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapy, 5-year survival is estimated as 9% to 20%.1,2 During the past decade, LC incidence has been increasing and age at the time of diagnosis continues to decrease.3,4 Median age at diagnosis is 70 years, and approximately 13% of all patients with LC are younger than age 50 years. Numerous studies have suggested that LC in young patients constitutes an entity with unique characteristics, such as a higher percentage of female patients, a lower rate of smoking history, a higher percentage of family history of LC, a higher rate of adenocarcinoma histology, and more advanced stage at diagnosis.5-13 However, it is still controversial whether youthful patients with LC have better or worse outcomes.14-16 In addition, most of the literature regarding young patients is associated with Asian cohorts, whereas less data about white communities are available. Currently, a considerable percentage of patients with non–small-cell lung cancer (NSCLC) benefit from personalized therapy protocols that are based on the genomic profile of tumors.17,18 Mutations in the epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) genes affect the prognosis of patients. Recent studies have shown that young patients with NSCLC harbor more driver mutations than older patients. The rate of mutations documented in the young white population varies between articles and is approximately 20% to 30% for EGFR mutation and 10% to 20% for ALK rearrangement.17-19 There are conflicting data on whether younger patients with NSCLC achieve better or worse outcomes compared with the older population, yet most studies show that younger patients have better survival rates.7-10 Identifying the clinicopathologic characteristics and making appropriate proactive molecular profiling of the youthful population can guide treatment strategy in the clinical setting. Therefore, in the current study, we carried out a comprehensive analysis of patient clinicopathologic features and clinical outcomes in both young (age ≤ 50 years) and older (age > 60 years) patients with NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被张同学采纳,获得10
刚刚
蛋挞完成签到 ,获得积分10
1秒前
小醋坛子君完成签到,获得积分10
1秒前
天梦星玄发布了新的文献求助10
1秒前
搜集达人的应助被TEDDY采纳,获得20
1秒前
小杰完成签到,获得积分10
2秒前
无花果的应助被zbn采纳,获得10
3秒前
4秒前
SL发布了新的文献求助10
4秒前
onion发布了新的文献求助10
4秒前
Shannon完成签到,获得积分10
4秒前
4秒前
5秒前
6秒前
充电宝的应助被热情的远锋采纳,获得10
6秒前
001发布了新的文献求助10
7秒前
9秒前
10秒前
CipherSage的应助被端庄书雁采纳,获得10
10秒前
稀饭发布了新的文献求助10
10秒前
丘比特的应助被牧百川采纳,获得10
10秒前
多多完成签到,获得积分10
10秒前
11秒前
上上上完成签到,获得积分10
11秒前
天天快乐的应助被daizao采纳,获得10
12秒前
12秒前
huang完成签到 ,获得积分10
13秒前
TEDDY发布了新的文献求助20
13秒前
星辰大海的应助被1001采纳,获得10
13秒前
稀饭完成签到,获得积分10
14秒前
gujun完成签到,获得积分20
15秒前
田様的应助被lsq采纳,获得10
15秒前
隐形太阳发布了新的文献求助30
16秒前
可爱的函函的应助被likemangren采纳,获得10
16秒前
范慧晨完成签到,获得积分10
16秒前
16秒前
碎觉觉发布了新的文献求助10
17秒前
今鱼完成签到 ,获得积分10
17秒前
Dani完成签到,获得积分10
17秒前
LIIII发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183298
求助须知:如何正确求助?哪些是违规求助? 9572606
关于积分的说明 21826444
捐赠科研通 7780272
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558136
邀请新用户注册赠送积分活动 2480259